Leonard Bell, Director at ALEXION PHARMACEUTICALS INC (ALXN), sold 34,210 shares at $135.07 ($4.7M) on 2017-01-05, disclosed to the SEC on 2017-01-09.
Seasonal sale ($4.7M) by Director — this insider has traded ALXN in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $135.07 | 17,105 | $2.3M | 49.1% |
| 2 | $139.98 | 17,105 | $2.4M | 50.9% |
| Total | $137.52 avg | 34,210 | $4.7M | 100% |
| Filing → |
| ALXN | SELL | 2017-02-08 | $2.2M | — | Filing → |
| ALXN | SELL | 2017-01-13 | $14K | — | Filing → |
| ALXN | SELL | 2017-01-09 | $5.5M | — | Filing → |